Compare First-Line Meds for Parkinson’s

About 60,000 people in the US are diagnosed with Parkinson’s disease each year...and you’ll need to help sort through first-line meds.

Meds don’t slow progression, so consider using a “wait-and-see” approach...starting when symptoms impair function or quality of life.

Tailor med choice based on age, symptom severity, etc.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote